Case Report
Rhabdomyolysis due to Trimethoprim-Sulfamethoxazole Administration following a Hematopoietic Stem Cell Transplant
Table 1
Complete medication and dosing history with relevant laboratory values for our patient during first inpatient admission for rhabdomyolysis (September 9, 2013), discharge (September 12, 2013), and outpatient clinic follow-up visit (September 27, 2013). The same information is also presented for the second inpatient admission for rhabdomyolysis (October 3, 2013), discharge (October 6, 2013), and outpatient clinic follow-up visit (October 14, 2013).
|